PTPRC and neoplasm: Notably, the population of Batf3-dependent cross-presenting DCs—migratory CD103+ DCs (CD45+CD11b−MHCII+Lin−CD11c+CD103+)—was greater in the brains and TDLNs of mice implanted with FGL2KO tumor cells than in those of mice implanted with Ctrl tumor cells (Fig. 4a), and the population of CD8a+ DCs (CD45+CD11b−MHCII+Lin−CD11c+CD8a+) was not significantly different between the two groups, showing that numbers of migratory antigen-presenting DCs was increased by intracerebral implantation of FGL2KO tumor cells.